Haemophagocytic lymphohistiocytosis after ChAdOx1 nCoV-19 vaccination

J Clin Pathol. 2022 Apr;75(4):282-284. doi: 10.1136/jclinpath-2021-207760. Epub 2021 Jul 22.

Authors

Luke Attwell¹, Than Zaw², Jill McCormick³, Jonathan Marks⁴, Helen McCarthy²

Affiliations

¹ Department of Haematology, Dorset County Hospital NHS Foundation Trust, Dorchester, UK lukeattwell@doctors.org.uk.
² Department of Haematology, University Hospitals Dorset NHS Foundation Trust, Bournemouth, UK.
³ Department of Haematology, Dorset County Hospital NHS Foundation Trust, Dorchester, UK.
⁴ Department of Rheumatology, University Hospitals Dorset NHS Foundation Trust, Bournemouth, UK.

PMID: 34301797
DOI: 10.1136/jclinpath-2021-207760

No abstract available

Keywords: COVID-19; hematology; vaccines.

Publication types

Letter

MeSH terms

COVID-19* / prevention & control
ChAdOx1 nCoV-19
Humans
Lymphohistiocytosis, Hemophagocytic* / diagnosis
Lymphohistiocytosis, Hemophagocytic* / etiology
Vaccination / adverse effects

Substances

ChAdOx1 nCoV-19